ZINC ADJUVANT TREATMENT IN SARS-CoV-2: A RANDOMIZED CLINICAL TRIAL.

MLA

Gómez-Zorrilla, Silvia, et al. “ZINC ADJUVANT TREATMENT IN SARS-CoV-2: A RANDOMIZED CLINICAL TRIAL.” Topics in Antiviral Medicine, vol. 31, no. 2, Apr. 2023, p. 213. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303790&authtype=sso&custid=ns315887.

APA

Gómez-Zorrilla, S., Du, J., Sendra, E., Espona, M., Siverio, A., Rodríguez-Alarcon, A., Navarro-Valls, C., Rins-Lozano, O., Ruano, E. C., Arrieta-Aldea, I., Fierro-Villegas, A., Plata, C., Garcia-Giralt, N., Vicente, R., & Guerri-Fernandez, R. (2023). ZINC ADJUVANT TREATMENT IN SARS-CoV-2: A RANDOMIZED CLINICAL TRIAL. Topics in Antiviral Medicine, 31(2), 213.

Chicago

Gómez-Zorrilla, Silvia, Juan Du, Elena Sendra, Merce Espona, Ana Siverio, Alicia Rodríguez-Alarcon, Claudia Navarro-Valls, et al. 2023. “ZINC ADJUVANT TREATMENT IN SARS-CoV-2: A RANDOMIZED CLINICAL TRIAL.” Topics in Antiviral Medicine 31 (2): 213. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303790&authtype=sso&custid=ns315887.